Seizure susceptibility relates to microglial TREM2 expression and morphology in a multiple repeated low-dose kainic

Hyo Jung Shin1, In Soo Kim2, Minwoo Kim3

  • 1Department of Biochemistry and Cell Biology, Eulji University School of Medicine, Daejeon 34824, Republic of Korea.

PubMed

Insights

Microglia, the brain's immune cells, change their phenotype and increase TREM2 expression in seizure-susceptible mice. This highlights their role in epilepsy development and progression.

Area of Science:

  • Neuroscience
  • Immunology
  • Epilepsy Research

Background:

  • Microglia are crucial for brain homeostasis.
  • Seizure susceptibility involves complex changes in brain immunity.
  • Understanding microglial roles is key to epilepsy research.

Purpose of the Study:

  • Investigate microglial phenotype changes related to seizure susceptibility.
  • Analyze gene expression patterns in microglial phagocytosis.
  • Determine the role of microglia in seizure progression.

Main Methods:

  • Induced status epilepticus (SE) using kainic acid (KA) in mice.
  • Classified mice into seizure-resistant, tolerant, and susceptible groups.
  • Analyzed hippocampal tissue and gene expression (GSE88992).
  • Utilized immunofluorescence staining for TREM2 expression.

Main Results:

  • Neuronal loss varied across hippocampal regions in seizure groups.
  • Significant differences in microglial phenotypes were observed between groups.
  • Increased triggering receptor expressed on myeloid cells (TREM2) expression in microglia of seizure-susceptible mice.
  • Microglial changes correlate with seizure progression.

Conclusions:

  • Microglial phenotypes and TREM2 expression differ significantly based on seizure susceptibility.
  • Microglia play a vital role in the transition from initial seizures to epilepsy.
  • This study provides insights into microglial involvement in epilepsy development.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.3K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
791